Cycle 3 Cohort of the IMPACT Accelerator, sponsored by Hologic
Augment Health is building a smart, non-invasive bladder fullness monitor to improve care for people with neurological conditions.
Scailyte specializes in generating actionable insights/biosignatures from multi-omics single-cell data using AI..
3Daughters is developing a long-acting reversible contraceptive designed to improve upon the outdated T-shape design of current intrauterine devices (IUDs).
NIRAMAI has developed a novel software-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination.
Curiva's platform technology, diaPatchTM, is a noninvasive diagnostic patch designed for the early detection of gynecologic malignancies.
BioSens8 mines microbes using its platform technology to engineer novel biosensors to address unmet diagnostic needs.
Cx Therapeutics is developing a medical device to reduce preterm birth and improve outcomes for pregnant women with cervical insufficiency.
Using their patented biomimetic membrane for sperm selection, they universalize the access to fertility treatments by allowing intrauterine insemination comfortably at patients' homes.
Nesa is transforming women’s health by developing a novel incision-less, safe, effective and uterus preserving technology to treat uterine fibroids.
Endotelix is dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome, including diagnostic tests and therapies.